TOP STORIES

• REGULATORY Experts Doubt Necessity of Policy Intervention for LLP-Dependent Companies
  January 27, 2023

• REGULATORY Chuikyo Begins Xocova Price Debate under Mega Seller Rule, Weighs Quicker Re-Pricing
  January 26, 2023

• ORGANIZATION PhRMA Poised to Issue 2024 Reform Proposal in Next Few Months: New Japan Chief
  January 25, 2023

• REGULATORY Xocova Might Trigger Mega Seller Price Control Rule for First Time
  January 24, 2023

• REGULATORY Setting “Presumed Efficacy” Criteria Would Be Difficult; Xocova Decision Reasonable: PMDA Chief
  January 23, 2023

• BUSINESS Opdivo Outdistances Keytruda in 2022 with Sales Up 30 Billion Yen YOY: Encise
  January 20, 2023

• REGULATORY Former Minister Nemoto to Initiate Debates on Pharma Policies by Young Lawmakers
  January 19, 2023

• BUSINESS Ex-Sandoz Japan Chief Tapped to Spearhead Nichi-Iko Turnaround
  January 18, 2023

• REGULATORY Ex-Minister Tamura Hightlights Need for Rewarding Innovation towards FY2024 Drug Reform
  January 17, 2023

• ORGANIZATION Japan Pharma Lobbies Look Set to Shift to Okada/Ueno Leadership towards FY2024 Reform
  January 17, 2023

• BUSINESS Alzheimer’s Med Lecanemab Submitted in Japan: Eisai
  January 16, 2023

• REGULATORY Experts Call for Deregulations for Orphan Support, English Dossiers to Foster Biotech Ecosystem
  January 16, 2023

• BUSINESS Daiichi Sankyo Files First Home-Developed mRNA COVID Vaccine in Japan
  January 16, 2023

• BUSINESS Janssen Vows to Offer New Positions for Employees Shown Exit Door: 1st Labor Talks
  January 13, 2023

• REGULATORY PMP, Off-Patent Drug Rules to Be Major Topics for 2024 Reform: MHLW Pharma Management Director
  January 12, 2023

• BUSINESS Eisai Files Alzheimer’s Med Lecanemab in Europe
  January 12, 2023

• ORGANIZATION FPMAJ Chief Poised to Push Rethink of Price Revision Rules towards FY2024 Reform
  January 11, 2023

• BUSINESS Leqembi Likely to Hit Peak Sales after 2030, US$26,500 Price Matches Value: Eisai CEO
  January 10, 2023

• BUSINESS Lecanemab Nabs Accelerated Approval in US, Set to Hit Market Late January
  January 10, 2023

• REGULATORY MHLW Eyes April Proposal to Push Generic Industry Shake-Up: Asst. Vice Minister
  January 6, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• …
• Next ›
• 最終 »